Stock listing

Frankfurt:2H0 Exicure, Inc. Aktie

German listing (Frankfurt) of Exicure, Inc. · home listing NASDAQ:XCUR

Follow Exicure, Inc. into a list and get an email when it puts out news.

Share price · FWB:2H0

€0.71 EUR -0.11 (-13.4%)

Close on Nov 20, 2026

Past year -78.3% · daily closes, Nov 20, 2025 – Nov 12, 2026, adjusted for splits
Day range
€0.71 – €0.84 EURNov 20, 2026
Market cap
€4.65M EURAt the close on Nov 20, 2026 · price × 6.55M shares outstanding
52-week range
€0.589 – €8.19 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€100 EURMedian day 0 shares · 56 days with no trades · last 3 months, Aug 20, 2026 – Nov 12, 2026
Exicure, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:XCUR · Home$0.90 USD-0.14 (-13.5%)32,146$1.00$1.00$0.90$1.04Close on Nov 20, 2026
Frankfurt:2H0€0.71 EUR-0.11 (-13.4%)—€0.84€0.84€0.71€0.82Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 12, 2026 · FWB:2H0 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.867+0.045+5.5%€0.946€0.947€0.8610
€0.822+0.232+39.3%€0.914€0.917€0.7930
€0.59-0.112-16.0%€0.743€0.749€0.589320
€0.702+0.01+1.4%€0.801€0.803€0.690
€0.692-0.028-3.9%€0.729€0.736€0.6730
€0.72-0.019-2.6%€0.827€0.827€0.7030
€0.739-0.039-5.0%€0.856€0.857€0.7290
€0.778+0.011+1.4%€0.849€0.854€0.7710
€0.767-0.024-3.0%€0.882€0.882€0.7650
€0.791+0.07+9.7%€0.791€0.791€0.7910
€0.721-0.215-23.0%€0.851€0.855€0.7160
€0.936+0.113+13.7%€0.936€0.936€0.9360
€0.823-0.005-0.6%€0.884€0.891€0.8110
€0.828-0.123-12.9%€0.878€0.88€0.8240
€0.951-0.049-4.9%€0.951€0.951€0.9514,076
€1.00+0.207+26.1%€1.00€1.00€1.000
€0.793-0.019-2.3%€0.836€0.839€0.7930
€0.812-0.037-4.4%€0.871€0.873€0.8060
€0.849-0.105-11.0%€0.952€0.953€0.8440
€0.954+0.075+8.5%€0.954€0.954€0.9540
€0.879-0.103-10.5%€1.022€1.023€0.8790
€0.982+0.048+5.1%€0.982€0.982€0.9820
€0.934+0.054+6.1%€0.934€0.934€0.9340
€0.88+0.034+4.0%€0.88€0.88€0.880
€0.846-0.013-1.5%€0.846€0.846€0.8460
€0.859+0.056+7.0%€0.859€0.859€0.8590
€0.803-0.049-5.8%€0.904€0.908€0.8010
€0.852+0.076+9.8%€0.71€0.91€0.6980
€0.776-0.147-15.9%€0.776€0.776€0.7760
€0.923+0.04+4.5%€0.807€0.925€0.7961,000
€0.883+0.122+16.0%€0.813€0.898€0.8080
€0.761-0.074-8.9%€0.761€0.761€0.7610
€0.835+0.013+1.6%€0.835€0.835€0.8350
€0.822-0.11-11.8%€0.822€0.822€0.8220
€0.932-0.023-2.4%€0.837€0.933€0.8360
€0.955-0.037-3.7%€0.835€0.966€0.8270
€0.992+0.037+3.9%€0.882€0.994€0.8790
€0.955-0.004-0.4%€0.858€0.955€0.8580
€0.959-0.009-0.9%€0.83€0.962€0.8230
€0.968+0.053+5.8%€0.925€0.978€0.9220
€0.915+0.035+4.0%€0.915€0.915€0.9150
€0.88-0.092-9.5%€0.88€0.88€0.880
€0.972-0.069-6.6%€0.934€0.988€0.9330
€1.041+0.105+11.2%€0.964€1.053€0.9540
€0.936-0.05-5.1%€0.936€0.936€0.9360
€0.986-0.11-10.0%€0.986€0.986€0.9860
€1.096+0.283+34.8%€0.975€1.104€0.9720
€0.813-0.155-16.0%€0.813€0.813€0.8130
€0.968+0.154+18.9%€0.968€0.968€0.9680
€0.814-0.048-5.6%€0.814€0.814€0.81412
€0.862-0.016-1.8%€0.862€0.862€0.8620
€0.8780.000.0%€0.878€0.878€0.8780
€0.878+0.017+2.0%€0.878€0.878€0.8780
€0.861-0.099-10.3%€0.861€0.861€0.8610
€0.96+0.055+6.1%€0.96€0.96€0.960
€0.905+0.137+17.8%€0.905€0.905€0.9050
€0.768+0.031+4.2%€0.768€0.768€0.7680
€0.737+0.01+1.4%€0.737€0.737€0.7370
€0.727-0.13-15.2%€0.727€0.727€0.7270
€0.857-0.134-13.5%€0.857€0.857€0.8571,300
€0.991+0.007+0.7%€0.991€0.991€0.9910

Splits

2 splits since 2022 · FWB:2H0 · every price before a split is adjusted for it

DayRatioWhat
1-for-5Consolidation
1-for-30Consolidation
Ticker
Frankfurt:2H0
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Exicure, Inc. news

Exicure, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
13 in the last 12 months · 120 in all · newest Nov 20, 2026 · oldest 2019
Decks
6 decks · latest Jan 5, 2022

Where Exicure, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:XCUR · Home listingNASDAQUnited StatesUSD
Munich:2H0MunichGermanyEUR
LS Exchange:A40L5CLS ExchangeGermanyEUR
BOATS:XCURBOATSUnited StatesUSD
Lang & Schwarz:A40L5CLang & SchwarzGermanyEUR
gettex:2H0gettexGermanyEUR
Frankfurt:2H0 · This pageFrankfurtGermanyEUR
Stuttgart:2H0StuttgartGermanyEUR
Tradegate:2H0TradegateGermanyEUR

Valuation

Price/book 3.1× against a median of 1.0×: 8th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$4.67M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
3.1×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
0.49

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Exicure, Inc. · NASDAQ:XCURUS$5.89MUS$4.67Mn/an/an/a3.1×n/a0.0×0.49
Acurx Pharmaceuticals, Inc. · NASDAQ:ACXPUS$6.30M−US$3.35Mn/an/an/a0.9×n/a0.0×1.31
TrivarX Limited · ASX:TRIUS$6.11MUS$4.58Mn/an/an/a0.6×n/a0.0×n/a
Enveric Biosciences, Inc. · NASDAQ:ENVBUS$6.04MUS$429,455n/an/an/a1.1×n/a0.0×0.76
Medicofarma Biotech Spolka Akcyjna · NEWCONNECT:MDBUS$6.03MUS$6.03Mn/a314×n/a5.4×n/a0.0×n/a
Addex Therapeutics Ltd · SIX:ADXNUS$5.96MUS$5.13Mn/a68.2×n/a2.6×n/a0.0×n/a
Argenica Therapeutics Ltd · ASX:AGNUS$5.95MUS$1.74Mn/an/an/a1.5×n/a0.0×n/a
Marvel Biosciences Corp · TSXV:MRVLUS$5.91MUS$6.04Mn/an/an/an/an/an/a0.91
Tempest Therapeutics, Inc. · NASDAQ:TPSTUS$5.74MUS$4.84Mn/an/an/an/an/an/a1.09
Oncotelic Therapeutics Inc · OTC:OTLCUS$5.58MUS$5.52M0.0×n/an/a0.0×n/a0.0×0.07
Theriva Biologics, Inc. · AMEX:TOVXUS$5.51MUS$461,120n/an/an/a0.5×n/a0.3×2.65
Median of the othersUS$5.96MUS$4.71M0.0×191×1.0×0.0×1.00

Events

QuarterResultsShare move
Q3 2026Nov 20, 2026
Q2 2026Aug 14, 2026+5.3%
Q3 2025Nov 7, 2025−8.9%
Q2 2025Aug 8, 2025+3.0%
Q1 2025Jun 4, 2025 · After close−2.5%
Q4 2024Mar 20, 2025+8.9%
Q3 2024Nov 15, 2024+23.9%
Q2 2024Aug 13, 2024 · After close−25.6%
Q1 2024Jun 17, 2024 · After close+4.7%
Q4 2023Mar 7, 2024−0.1%
All 20 quarters
QuarterResultsShare move
Q3 2023Nov 16, 2023+3.5%
Q2 2023Aug 11, 2023 · After close−2.6%
Q4 2022Mar 27, 2023 · After close−10.8%
Q3 2022Nov 14, 2022 · After close−8.7%
Q2 2022Aug 15, 2022 · After close−3.5%
Q1 2022May 16, 2022 · After close+9.2%
Q4 2021Mar 25, 2022 · After close−24.1%
Q3 2021Nov 19, 2021 · Before open−30.1%
Quarter to Jun 30, 2021Aug 12, 2021 · Before open+3.4%
Quarter to Mar 31, 2021May 12, 2021 · After close−8.3%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2022)Investor deck23 slidesJan 5, 2022
Investor Presentation (August 2021)Investor deck42 slidesAug 5, 2021
Investor Presentation (April 2021)Investor deck39 slidesApr 9, 2021
Investor Day (January 2021)Investor day72 slidesJan 7, 2021
Technical Presentation (September 2020)Technical91 slidesSep 16, 2020
Corporate Update (June 2019)Corporate update13 slidesJun 27, 2019

Open Decks

Financings

RaiseDate
Strategic investment of shares of common stock
Closed: US$8.7M raised
Use of proceeds: Mainly the acquisition of GPCR USA, clinical trial costs and ongoing operations
Dec 26, 2024

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0500.0K028.8M-483.0K16.6M1.30M118.0K9.72M1.04M
Cost of revenue460.0K824.0K1.42M1.86M1.78M32.1M14.1M14.1M13.1M13.7M
Gross profit-460.0K500.0K-1.42M27.0M-483.0K-15.5M1.30M118.0K-3.36M-12.6M
Research and development3.29M01.42M19.8M49.0M32.1M19.3M14.1M13.1M13.7M
Selling, general and administrative6.83M5.45M12.7M10.9M13.1M9.96M8.57M7.82M7.05M3.54M
Operating income-4.23M-12.2M-15.0M-1.83M-62.5M-25.4M-26.6M-21.8M-10.4M-16.2M
Depreciation and amortization242.0K28.0K634.0K1.16M1.12M766.0K392.0K358.0K232.0K180.0K
EBITDA-3.99M-12.2M-14.4M-668.0K-61.4M-24.7M-26.2M-21.5M-10.2M-16.0M
Interest expense1.00K18.0K0595.0K1.69M573.0K786.0K672.0K795.0K724.0K
Income before tax-5.58M-9.69M-16.9M-2.37M-64.1M-24.7M-26.3M-22.4M-12.0M-16.9M
Income tax-634.0K8.00K0209.0K000000
Net income-4.95M-9.70M-16.9M-2.58M-64.1M-24.7M-26.3M-22.4M-11.0M-16.9M
Earnings per share, basic-0.79-4.75-10.55-0.56-21.70-0.28-0.46-0.54-1.09-149.37
Earnings per share, diluted-0.79-4.75-10.55-0.56-21.70-0.28-0.46-0.54-1.09-149.37

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents3.75M12.5M816.0K8.58M34.6M33.3M48.5M26.3M25.8M19.6M
Short-term investments04.50M48.8M62.3M0
Receivables58.0K521.0K250.0K111.0K011.0K16.0K0015.0K
Inventory-250.0K510.0K3.03M646.0K646.0K
Current assets4.62M13.7M2.02M10.1M43.7M86.3M112.8M27.7M27.6M20.0M
Property, plant and equipment306.0K26.0K54.0K2.53M3.93M4.12M2.10M1.06M1.32M503.0K
Goodwill4.40M0
Total assets14.0M15.1M11.6M23.3M64.9M100.4M115.3M28.8M29.0M20.6M
Accounts payable1.69M1.03M1.63M361.0K3.41M1.87M1.81M500.0K1.05M509.0K
Current liabilities3.89M3.07M2.51M1.64M34.1M13.7M31.1M2.04M3.36M12.2M
Long-term debt016.6M04.92M4.86M4.45M
Total debt176.0K5.93M006.87M16.6M4.96M4.92M4.86M5.67M
Total liabilities10.1M8.28M8.55M8.41M53.6M38.9M34.5M7.80M9.01M18.1M
Shareholders' equity3.93M6.77M3.03M14.9M11.2M61.5M80.7M21.0M20.0M2.45M
Shares outstanding6.37M6.03M1.83M4.97M3.63M87.7M86.1M44.4M39.3M131.6K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-8.55M-2.91M-10.4M-35.7M-34.8M-39.3M1.32M-19.5M-19.8M-5.05M
Capital spending-1.00K00-10.0K-968.0K-3.17M-1.08M-94.0K-926.0K-394.0K
Free cash flow-8.56M-2.91M-10.4M-35.7M-35.8M-42.4M235.0K-19.6M-20.7M-5.44M
Cash from investing-1.81M0-1.08M4.70M43.1M10.1M-63.4M-94.0K-926.0K-394.0K
Cash from financing1.60M13.4M3.67M-3.10M1.12M15.1M84.3M20.1M26.9M6.34M
Share buybacks-800.0K-4.00K-14.0K3.34M90.8M22.0M31.6M483.0K
Change in cash-8.76M10.5M-7.76M-34.1M9.38M-14.0M22.2M504.0K6.14M892.0K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 20, 2026Quarterly reportSEC
8-K · Current reportNov 20, 2026Current reportSEC
NT 10-Q · Late filing noticeNov 16, 2026Explanation requestSEC
DEF 14A · Proxy statementNov 12, 2026Meeting noticeSEC
8-K · Current reportNov 10, 2026Material contractSEC
PRE 14A · Preliminary proxy statementNov 2, 2026Meeting noticeSEC
8-K · Current reportSep 16, 2026Current reportSEC
10-Q · Quarterly reportAug 14, 2026Quarterly reportSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 17, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportJun 30, 2026Management or board changeSEC
8-K · Current reportJun 1, 2026Current reportSEC
10-Q · Quarterly reportMay 29, 2026Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2026Explanation requestSEC
8-K · Current reportApr 10, 2026Management or board changeSEC
8-K · Current reportApr 2, 2026Current reportSEC
8-K · Current reportMar 27, 2026Management or board changeSEC
10-K · Annual reportMar 25, 2026Annual reportSEC
8-K · Current reportMar 25, 2026ResultsSEC
4 · Change in ownershipFeb 19, 2026Insider tradeSEC
8-K · Current reportFeb 17, 2026Management or board changeSEC
8-K · Current reportFeb 10, 2026Management or board changeSEC
8-K · Current reportJan 22, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 21, 2026Big-stake noticeSEC
4 · Change in ownershipJan 21, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 20, 2026Big-stake noticeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 9, 2026Big-stake noticeSEC
4 · Change in ownershipJan 8, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedDec 10, 2025Big-stake noticeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipNov 19, 2025Insider tradeSEC
8-K · Current reportNov 17, 2025Current reportSEC
8-K · Current reportNov 10, 2025Meeting outcomeSEC
10-Q · Quarterly reportNov 7, 2025Quarterly reportSEC
8-K · Current reportNov 7, 2025ResultsSEC
3 · Initial statement of ownershipSep 29, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 29, 2025Insider tradeSEC
DEF 14A · Proxy statementSep 23, 2025Meeting noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 22, 2025Big-stake noticeSEC
8-K · Current reportSep 9, 2025Management or board changeSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
10-Q · Quarterly reportAug 8, 2025Quarterly reportSEC
8-K · Current reportAug 8, 2025ResultsSEC
8-K · Current reportAug 4, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveJul 23, 2025Other filingsSEC
424B3 · ProspectusJul 22, 2025Offer documentSEC
CORRESP · Letter to the SECJul 18, 2025Other filingsSEC
UPLOAD · Letter from the SECJul 17, 2025Other filingsSEC
S-1 · Registration statementJul 14, 2025Offer documentSEC
10-Q · Quarterly reportJun 27, 2025Quarterly reportSEC
8-K · Current reportJun 27, 2025Current reportSEC
8-K · Current reportJun 10, 2025Management or board changeSEC
8-K · Current reportMay 28, 2025Current reportSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
NT 10-Q · Late filing noticeMay 15, 2025Explanation requestSEC
8-K · Current reportMay 6, 2025Material contractSEC
8-K · Current reportApr 14, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 26, 2025Big-stake noticeSEC
4 · Change in ownershipMar 26, 2025Insider tradeSEC
3 · Initial statement of ownershipMar 24, 2025Insider tradeSEC
3 · Initial statement of ownershipMar 24, 2025Insider tradeSEC
3 · Initial statement of ownershipMar 24, 2025Insider tradeSEC
3 · Initial statement of ownershipMar 24, 2025Insider tradeSEC
10-K · Annual reportMar 18, 2025Annual reportSEC
8-K · Current reportMar 18, 2025ResultsSEC
8-K · Current reportMar 5, 2025Management or board changeSEC
4 · Change in ownershipFeb 24, 2025Insider tradeSEC
8-K · Current reportFeb 21, 2025Material contractSEC
8-K/A · Current report, amendedJan 23, 2025Current reportSEC
8-K · Current reportJan 22, 2025Material contractSEC
8-K · Current reportJan 6, 2025Management or board changeSEC
8-K · Current reportDec 26, 2024Current reportSEC
8-K/A · Current report, amendedDec 26, 2024Current reportSEC
3 · Initial statement of ownershipDec 23, 2024Insider tradeSEC
SCHEDULE 13G · Big-stake noticeDec 23, 2024Big-stake noticeSEC
8-K · Current reportDec 20, 2024Management or board changeSEC
8-K · Current reportDec 17, 2024Current reportSEC
8-K · Current reportDec 11, 2024Material contractSEC
DEF 14A · Proxy statementDec 2, 2024Meeting noticeSEC
SC 13D · Big-stake noticeNov 29, 2024Big-stake noticeSEC
3 · Initial statement of ownershipNov 29, 2024Insider tradeSEC
4 · Change in ownershipNov 26, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 26, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 26, 2024Insider tradeSEC
8-K · Current reportNov 25, 2024Management or board changeSEC
PRE 14A · Preliminary proxy statementNov 22, 2024Meeting noticeSEC
8-K · Current reportNov 20, 2024Current reportSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
8-K · Current reportNov 14, 2024ResultsSEC
8-K · Current reportSep 30, 2024Acquisition or disposalSEC
8-K · Current reportSep 18, 2024Current reportSEC
4 · Change in ownershipSep 16, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedSep 16, 2024Big-stake noticeSEC
8-K · Current reportSep 13, 2024Material contractSEC
8-K · Current reportAug 26, 2024Meeting outcomeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
8-K · Current reportAug 19, 2024Current reportSEC
8-K · Current reportAug 15, 2024Current reportSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
8-K · Current reportAug 13, 2024Current reportSEC
SC 13D/A · Big-stake notice, amendedAug 5, 2024Big-stake noticeSEC
8-K · Current reportAug 1, 2024Current reportSEC
DEF 14A · Proxy statementJul 30, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementJul 19, 2024Meeting noticeSEC
SC 13D/A · Big-stake notice, amendedJul 2, 2024Big-stake noticeSEC
8-K · Current reportJul 1, 2024Meeting outcomeSEC
8-K · Current reportJun 25, 2024Current reportSEC
10-Q · Quarterly reportJun 17, 2024Quarterly reportSEC
8-K · Current reportJun 17, 2024ResultsSEC
ARS · Annual report to shareholdersJun 11, 2024Annual reportSEC
DEF 14A · Proxy statementJun 11, 2024Meeting noticeSEC
10-K · Annual reportJun 6, 2024Annual reportSEC
8-K · Current reportJun 6, 2024ResultsSEC
10-Q/A · Quarterly report, amendedJun 6, 2024Quarterly reportSEC
10-Q/A · Quarterly report, amendedJun 6, 2024Quarterly reportSEC
8-K · Current reportMay 23, 2024Current reportSEC
4 · Change in ownershipMay 23, 2024Insider tradeSEC
10-Q · Quarterly reportMay 16, 2024Quarterly reportSEC
8-K · Current reportMay 16, 2024ResultsSEC
10-Q/A · Quarterly report, amendedMay 16, 2024Quarterly reportSEC
10-Q/A · Quarterly report, amendedMay 16, 2024Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2024Explanation requestSEC
8-K · Current reportApr 22, 2024Current reportSEC
NT 10-K · Late filing noticeApr 1, 2024Explanation requestSEC
4 · Change in ownershipMar 6, 2024Insider tradeSEC
4 · Change in ownershipMar 4, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedMar 4, 2024Big-stake noticeSEC
8-K · Current reportFeb 5, 2024Current reportSEC
8-K · Current reportJan 16, 2024Current reportSEC
4 · Change in ownershipDec 1, 2023Insider tradeSEC
8-K · Current reportDec 1, 2023Current reportSEC
8-K · Current reportNov 28, 2023Current reportSEC
NT 10-Q · Late filing noticeNov 14, 2023Explanation requestSEC
8-K · Current reportOct 6, 2023Current reportSEC
3 · Initial statement of ownershipSep 29, 2023Insider tradeSEC
8-K · Current reportSep 27, 2023Management or board changeSEC
8-K · Current reportSep 13, 2023Current reportSEC
3 · Initial statement of ownershipAug 31, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 31, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 31, 2023Insider tradeSEC
8-K · Current reportAug 23, 2023Management or board changeSEC
4 · Change in ownershipAug 18, 2023Insider tradeSEC
10-Q · Quarterly reportAug 11, 2023Quarterly reportSEC
8-K · Current reportAug 11, 2023ResultsSEC
8-K · Current reportAug 9, 2023Current reportSEC
SC 13D/A · Big-stake notice, amendedAug 7, 2023Big-stake noticeSEC
8-K · Current reportAug 4, 2023Management or board changeSEC
10-Q · Quarterly reportJul 14, 2023Quarterly reportSEC
8-K · Current reportJul 14, 2023ResultsSEC
SC 13D/A · Big-stake notice, amendedJun 28, 2023Big-stake noticeSEC
4 · Change in ownershipJun 27, 2023Insider tradeSEC
3 · Initial statement of ownershipJun 27, 2023Insider tradeSEC
8-K · Current reportJun 14, 2023Management or board changeSEC
8-K · Current reportJun 6, 2023Current reportSEC
8-K · Current reportJun 1, 2023Management or board changeSEC
8-K · Current reportMay 26, 2023Current reportSEC
4 · Change in ownershipMay 25, 2023Insider tradeSEC
8-K · Current reportMay 19, 2023Current reportSEC
8-K · Current reportMay 18, 2023Material contractSEC
SC 13D/A · Big-stake notice, amendedMay 16, 2023Big-stake noticeSEC
3 · Initial statement of ownershipMay 15, 2023Insider tradeSEC
3/A · Initial statement of ownership, amendedMay 15, 2023Insider tradeSEC
NT 10-Q · Late filing noticeMay 15, 2023Explanation requestSEC
8-K · Current reportMay 11, 2023Current reportSEC
3 · Initial statement of ownershipMay 9, 2023Insider tradeSEC
8-K · Current reportMay 9, 2023Material contractSEC
3 · Initial statement of ownershipMay 5, 2023Insider tradeSEC
8-K · Current reportMay 4, 2023Current reportSEC
8-K · Current reportMay 2, 2023Management or board changeSEC
10-K/A · Annual report, amendedMay 1, 2023Annual reportSEC
SC 13D/A · Big-stake notice, amendedMay 1, 2023Big-stake noticeSEC
8-K · Current reportApr 27, 2023Current reportSEC
SC 13D/A · Big-stake notice, amendedApr 13, 2023Big-stake noticeSEC
10-K · Annual reportMar 27, 2023Annual reportSEC
8-K · Current reportMar 27, 2023ResultsSEC
4 · Change in ownershipMar 9, 2023Insider tradeSEC
3 · Initial statement of ownershipMar 9, 2023Insider tradeSEC
3 · Initial statement of ownershipMar 6, 2023Insider tradeSEC
3 · Initial statement of ownershipMar 6, 2023Insider tradeSEC
3 · Initial statement of ownershipMar 6, 2023Insider tradeSEC
3 · Initial statement of ownershipMar 6, 2023Insider tradeSEC
SC 13D/A · Big-stake notice, amendedMar 2, 2023Big-stake noticeSEC
8-K · Current reportMar 2, 2023Management or board changeSEC
8-K · Current reportFeb 24, 2023Management or board changeSEC
8-K · Current reportFeb 21, 2023Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedFeb 13, 2023Big-stake noticeSEC
8-K · Current reportFeb 10, 2023Management or board changeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2023Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedJan 20, 2023Big-stake noticeSEC
8-K · Current reportJan 20, 2023Management or board changeSEC
4 · Change in ownershipJan 4, 2023Insider tradeSEC
3 · Initial statement of ownershipJan 4, 2023Insider tradeSEC
8-K · Current reportDec 30, 2022Management or board changeSEC
4 · Change in ownershipDec 19, 2022Insider tradeSEC
SC 13D/A · Big-stake notice, amendedDec 19, 2022Big-stake noticeSEC
8-K · Current reportDec 16, 2022Management or board changeSEC
DEFA14A · Additional proxy materialDec 14, 2022Meeting noticeSEC
8-K · Current reportDec 14, 2022Current reportSEC

This page holds 200 of 537 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Exicure, Inc.’s releases · as of Nov 18, 2026

Common shares
6,545,995
Fully diluted
6,545,995

Fully diluted

LineSharesAs of
Common shares6,545,995Nov 18, 2026

Share count over time

CountShares
Nov 18, 20266,545,995

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Citadel85,9931.3%US$98,892Sep 30, 2026
Vanguard42,0440.64%US$48,350Sep 30, 2026
Geode Capital40,4090.62%US$46,476Sep 30, 2026
Two Sigma13,2590.20%US$15,777Sep 30, 2026
Virtu Financial LLC13,2500.20%US$15,000Sep 30, 2026
Tower Research Capital LLC (TRC)5,0420.08%US$5,999Sep 30, 2026
UBS3,1490.05%US$3,748Sep 30, 2026
SBI Securities Co., Ltd.243<0.01%US$289Sep 30, 2026
Morgan Stanley138<0.01%US$164Sep 30, 2026
RBC82<0.01%Sep 30, 2026
All 17 holders
HolderSharesOf the companyValueAs of
BlackRock35<0.01%US$42Sep 30, 2026
Osaic Holdings, Inc.29<0.01%US$34Sep 30, 2026
Prestige Wealth Management Group LLC20<0.01%US$24Sep 30, 2026
Harbour Investments, Inc.17<0.01%US$20Sep 30, 2026
BNP Paribas4<0.01%US$5Sep 30, 2026
JPMorgan2<0.01%US$2Sep 30, 2026
Citigroup Inc1<0.01%US$1Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund28,8830.44%US$60,077Jun 30, 2026
Fidelity Extended Market Index Fund19,3670.30%US$61,974May 31, 2026
Vanguard Total Stock Market Index Fund14,2280.22%US$29,594Jun 30, 2026
Fidelity Total Market Index Fund4,7310.07%US$15,139May 31, 2026
Fidelity Series Total Market Index Fund3,6390.06%US$11,645May 31, 2026
Fidelity Nasdaq Composite Index Fund2,9120.04%US$9,318May 31, 2026
Diversified Equity Alpha Master Portfolio35<0.01%US$73Jun 30, 2026

Big stakes

StakeStakeSharesDateFiling
Exicure HiTron Inc.34.90%2.22MJul 8, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bali Muralidhar
Other companies: Spruce Biosciences, Inc. (Director · Since at least Oct 8, 2020); OnKure Therapeutics, Inc. (Director · Apr 8, 2021 – Jun 6, 2023 · Past)
Director · Jun 2, 2021 – Jun 13, 2022 · Past
David Snyder
Other companies: Coya Therapeutics, Inc. (Chief Financial Officer & Chief Operating Officer · Since at least Dec 28, 2022)
Chief Financial Officer · Mar 12, 2020 – Mar 12, 2020 · Past
Aejin HwangDirector · Since at least Sep 8, 2025
Andy YooChief Restructuring Officer, Director · Nov 21, 2024 – Nov 21, 2024 · Past
Changil AhnDirector · Feb 24, 2023 – Feb 24, 2023 · Past
Chang Keun ChoiDirector · Dec 19, 2024 – Dec 19, 2024 · Past
Matthias SchroffChief Executive Officer, Director · Apr 16, 2018 – May 16, 2022 · Past
Min Woo KangDirector · Dec 19, 2024 – Dec 19, 2024 · Past
Seung Ik BaikDirector · Nov 21, 2024 – Nov 21, 2024 · Past
Uh Kang Paul SungDirector · Feb 24, 2023 – Feb 24, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Exicure, Inc.